Intervention

BPI-361175

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)NCT05393466 · 2026-07-01

NOT_YET_RECRUITING

A Phase 1/2 Study of BPI-361175 in Subjects With Advanced Solid TumorsNCT05329298 · 2021-07-21

Common conditions

Non-small Cell Lung Cancer1 Non-small Cell Lung Carcinoma1

Leading sponsors

Betta Pharmaceuticals Co., Ltd.1 Xcovery Holdings, Inc.1

Trial status mix

NOT_YET_RECRUITING1

UNKNOWN1

Phase mix

PHASE12

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.